OCG plans to add a product manager who will work to support sales of the Synergy Cervical disc in the EMEA regions, according to a Sept. 12 news release. It is the only artificial cervical disc with a 6-degree lordotic core. It is designed for patients with degenerative disc disease causing radiculopathy or myelopathy.
The Synergy disc is commercially available in Australia, New Zealand, Europe and Canada. It is designated for investigational use in the U.S.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.